Clinical trial

Lowering Events in Non-proliferative Retinopathy in Scotland

NCT03439345

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-23

PhasePHASE4

Study timeline

Study start (actual)2018-07-23Date precision: day

Registry last updated2025-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyunresolved

Interventions

Fenofibrate 145 mgDRUG · verified · RxNorm: fenofibrate 145 MG

Placebo Oral TabletDRUG

Sponsors & collaborators

University of Oxfordlead sponsor

National Institute for Health Research, United Kingdomcollaborator

University of Glasgowcollaborator

University of Aberdeencollaborator

University of Dundeecollaborator

University of Edinburghcollaborator

NHS Scotland Diabetic Retinopathy Screening Collaborativecollaborator

Mapped research locations

GlasgowUnited Kingdom1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03439345 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.